Next, we established a DIO disease model by maintaining C57BL/6J mice on a Gubra amylin NASH (GAN) diet, which has been shown to not only increase body weight but also reliably induce metabolic and liver histopathological changes (34). This evidence concerns the gene IAPP and metabolic dysfunction-associated steatohepatitis.